Alligator Bioscience
0,008
SEK
-1,2 %
Mindre end 1K følgere
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
-1,2%
-78,36%
-61,05%
-65,85%
-92,69%
-91,22%
-92,43%
-96,83%
-99,52%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Læs mereMarkedsværdi
138,63 mio. SEK
Aktieomsætning
1,95 mio. SEK
Omsætning
57,77 mio.
EBIT %
-396,64 %
P/E
-
Udbytteafkast, %
-
Finanskalender
27.3
2025
Ekstraordinær generalforsamling '24
24.4
2025
Delårsrapport Q1'25
5.7
2025
Generalforsamling '25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Alligator Bioscience: BioStock: Updated data further bolsters Alligator's mitazalimab
Alligator Bioscience Announces Continued Encouraging Overall Survival Benefit for Mitazalimab
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools